News from the College

  • High-Stakes Advocacy — James Metz, M.D., and his team work to keep every Vermont child safe
    October 14, 2020
    “Ensuring children are empowered and raised to become healthy, happy, productive members of our communities is one of the most important things we can do,” says assistant professor of pediatrics at the University of Vermont Larner College of Medicine James Metz, M.D. “Child abuse needs to be brought out from the underbelly of society. It’s easy for people to say ‘the problem is too big; it’s too difficult; it’s too sad.’ But that’s when you need to step into a problem, not away from it.”
  • Majumdar Research Shows How SARS-CoV-2 Robs Cell’s Ability to Sound Alarm and Fight
    October 8, 2020
    New research, published by scientists at the University of Vermont and Caltech in the journal Cell, has pinpointed three specific mechanisms that allow SARS-CoV-2 to incapacitate human cells by disabling the cell’s alarm system to call for help or warn nearby cells of infection.
  • Nelson Delivers NIH Director’s Wednesday Afternoon Lecture
    October 7, 2020
    Internationally recognized cerebral blood flow expert and University of Vermont Distinguished Professor and Chair of Pharmacology Mark Nelson, Ph.D., delivered a National Institutes of Health (NIH) Director’s Wednesday Afternoon Lecture, titled “Translating Thought into Blood Flow in the Brain: Capillaries as Sensors of Neural Activity,” on October 14.
  • Botten, Bruce & Colleagues' Study Describes Streamlined COVID-19 Test
    October 5, 2020
    A team of scientists at the University of Vermont, working in partnership with a group at the University of Washington, has developed a method of testing for the COVID-19 virus that doesn’t make use of these chemicals but still delivers an accurate result, paving the way for inexpensive, widely available testing in both developing countries and industrialized nations like the United States, where reagent supplies are again in short supply.
  • Remote Medical Reunion Features Lectures, Awards, Celebrations & More Oct. 1-10
    September 29, 2020
    The University of Vermont's Medical Reunion has been transformed into a 10-day online celebration for 2020 that runs from October 1 through 10 and allows Larner College of Medicine alumni from across the country and globe to gather safely in a virtual setting.
  • UVM & VT United Ways Survey Puts Health Priority-Setting in Hands of Community
    September 24, 2020
    Vermont United Ways and the Larner College of Medicine at the University of Vermont are providing Vermonters with a say in prioritizing community health needs via a survey that is the largest and most comprehensive public health project ever conducted by UVM medical students.
  • Tandoh Invested as Inaugural Gamelli Green and Gold Professor of Surgery
    September 23, 2020
    Margaret A. Tandoh, M.D., F.A.C.S, an expert in trauma, burn, and wound care and acute care surgery, has been invested as the inaugural Richard L. Gamelli, M.D.’74 Green and Gold Professor in Surgery at the University of Vermont’s Larner College of Medicine. The ceremony was held remotely on September 22, 2020.
  • New $5.4 Million NIH Grant Funds UVM Center for Biomedical Shared Resources ​
    September 21, 2020
    A new $5.47 million grant from the National Institutes of Health (NIH) to the University of Vermont Larner College of Medicine will support the creation of the UVM Center for Biomedical Shared Resources. The grant will fund completion of the Center's home on the first floor of the new Firestone Medical Research Building, which will be located on the south end of the Larner College of Medicine complex.
  • Plante Appointed Bloomfield Professor
    September 16, 2020
    Timothy Plante ’06 M.D.’10, M.H.S., assistant professor of medicine, has been appointed the Martin E. Bloomfield ’56 M.D.’60 and Judith S. Bloomfield ’59 Early Career Professor in Cardiovascular Research at the University of Vermont’s Larner College of Medicine.
  • Larner Team Plays Role in NIH COVID-19 Blood Clotting Treatment Trials
    September 10, 2020
    The University of Vermont (UVM) is participating in a major national research effort to evaluate the safety and effectiveness of varying types of blood thinners to treat adults diagnosed and hospitalized with COVID-19—the disease caused by SARS-CoV-2.